DONANEMAB
UNII 1ADB65P1KK

Substance Identification & Data

This profile provides standardized clinical and technical data for Donanemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1ADB65P1KK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1931944-80-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1ADB65P1KK

CAS Registry Number

1931944-80-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DONANEMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

1ADB65P1KK

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C166484

National Cancer Institute reference terminology for clinical and research data.

INN ID

10922

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-184

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Donanemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DONANEMAB

DONANEMAB-AZBT

Common Names & Synonyms

DONANEMAB [INN]

DONANEMAB [USAN]

DONANEMAB [WHO-DD]

DONANEMAB AZBT [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN PYROGLUTAMYL A.BETA. (3-X) PEPTIDE)(HUMAN CLONE LY3002813 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN CLONE LY3002813 .KAPPA.-CHAIN, DIMER

Brand / Trade Names

KISUNLA

Systematic Nomenclature

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS APP (AMYLOID BETA A4 PRECURSOR PROTEIN) A BETA 3-PYROGLUTAMYL PEPTIDES, A.BETA. 3 (3-X)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-444) (VH (HOMO SAPIENS IGHV1-3*01 (84.7%)-(IGHD)-IGHJ4*01 (91.7%)) (8.8.8) (1-115)-HOMO SAPIENS IGHG1*01 (100%) G1M17,1 (CH1 K120 (212) (116-213), HINGE (214-228), CH2 (229-338), CH3 D12 (354), L14 (356) (339-443), CHS K2>DEL (444)) (116-444)), (218-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV2-29*02 (89.0%)-IGKJ2*02 (100%)) (11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (158), V101 (196) (113'-219'))DIMER (224-224'':227-227'')-BISDISULFIDE

SYS